Related Experiment Video
Updated: Apr 20, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Kinase activity profiling reveals active signal transduction pathways in pediatric acute lymphoblastic leukemia: a
Naomi E van der Sligte1, Frank J G Scherpen, Tiny G J Meeuwsen-de Boer
1Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Abstract:
Still about 20% of patients with acute lymphoblastic leukemia (ALL) struggle with relapse, despite intensive chemotherapy. We and others have shown that kinase activity profiling is able to give more insights in active signal transduction pathways and point out interesting signaling hubs as well as new potential druggable targets. With this technique the gap between newly designed drugs and ALL may be bridged. The aim of this study was to perform kinome profiling on 20 pediatric ALL samples (14 BCP-ALL and six T-ALL) to identify signaling proteins relevant to ALL. We defined 250 peptides commonly activated in both BCP-ALL and T-ALL representing major signal transduction pathways including MAPK, PI3K/Akt, and regulators of the cell cycle/p53 pathway. For 27 peptides, differentially phosphorylation between BCP-ALL and T-ALL was observed. Among these, ten peptides were more highly phosphorylated in BCP-ALL while 17 peptides showed increased phosphorylation in T-ALL. Furthermore we selected one lead of the list of commonly activated peptides (HGFR_Y1235) in order to test its efficacy as a potential target and provide proof of principle for this approach. In conclusion kinome profiling is an elegant approach to study active signaling and identify interesting potential druggable targets.
Insights
Kinome profiling reveals key signaling pathways in pediatric acute lymphoblastic leukemia (ALL). This approach identifies potential drug targets to address treatment resistance in ALL patients.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Approximately 20% of acute lymphoblastic leukemia (ALL) patients experience relapse despite intensive chemotherapy.
- Kinase activity profiling offers insights into active signaling pathways and potential therapeutic targets in ALL.
- Identifying novel druggable targets is crucial for bridging the gap between drug development and ALL treatment.
Purpose of the Study:
- To perform kinome profiling on pediatric ALL samples to identify signaling proteins relevant to the disease.
- To characterize activated signaling pathways in both B-cell precursor ALL (BCP-ALL) and T-cell ALL (T-ALL).
- To identify differentially phosphorylated peptides between BCP-ALL and T-ALL for potential targeted therapy.
Main Methods:
- Kinome profiling was conducted on 20 pediatric ALL samples (14 BCP-ALL, 6 T-ALL).
- Peptide phosphorylation was analyzed to identify commonly activated and differentially phosphorylated signaling proteins.
- The efficacy of a selected target (HGFR_Y1235) was tested as a proof of principle.
Main Results:
- 250 peptides were commonly activated in both BCP-ALL and T-ALL, involving MAPK, PI3K/Akt, and cell cycle/p53 pathways.
- 27 peptides showed differential phosphorylation between BCP-ALL and T-ALL.
- Ten peptides were more phosphorylated in BCP-ALL, and 17 were more phosphorylated in T-ALL.
Conclusions:
- Kinome profiling is an effective method for studying active signaling in ALL.
- This technique can identify potential druggable targets for ALL treatment.
- Targeting specific signaling pathways may help overcome resistance in ALL.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases

